NCT02818036View on ClinicalTrials.gov

An fMRI Study of Opioid-related Changes in Neural Activity

NACompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

June 21, 2018

Study Completion Date

June 21, 2018

Conditions
Social Acceptance
Interventions
DRUG

Naltrexone

DRUG

Placebo

Trial Locations (1)

15260

University of Pittsburgh, Pittsburgh

All Listed Sponsors
lead

Tristen Inagaki

OTHER

NCT02818036 - An fMRI Study of Opioid-related Changes in Neural Activity | Biotech Hunter | Biotech Hunter